Home/Filings/4/0001209191-21-041455
4//SEC Filing

CATLIN AVERY W 4

Accession 0001209191-21-041455

CIK 0001595097other

Filed

Jun 16, 8:00 PM ET

Accepted

Jun 17, 4:40 PM ET

Size

7.9 KB

Accession

0001209191-21-041455

Insider Transaction Report

Form 4
Period: 2021-06-17
Transactions
  • Award

    Stock Option (right to buy)

    2021-06-17+58,20058,200 total
    Exercise: $2.07Exp: 2031-06-17Common Stock (58,200 underlying)
  • Award

    Stock Option (right to buy)

    2021-06-17+58,20058,200 total
    Exercise: $2.07Exp: 2031-06-17Common Stock (58,200 underlying)
Footnotes (2)
  • [F1]The annual option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. The option will vest in equal monthly installments over the course of 12 months beginning on the date of grant.
  • [F2]Represents a special retention award comprised of options to purchase common stock. The option will vest in equal monthly installments over the course of 12 months beginning on the date of grant.

Issuer

Corbus Pharmaceuticals Holdings, Inc.

CIK 0001595097

Entity typeother

Related Parties

1
  • filerCIK 0001255348

Filing Metadata

Form type
4
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 4:40 PM ET
Size
7.9 KB